Scrip's Stock Tracker - July 2009
This article was originally published in Scrip
Optimism was out of fashion in the US for most of last month. On July 22, First Trust Advisors chief economist Brian Wesbury dared to talk on the Yahoo techticker of what he called a looming V-shaped recovery, and of US GDP growth of 3.5% in H2 2009.
You may also be interested in...
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.
Germany’s COVID-19 testing strategy now permits the use and reimbursement of coronavirus antigen tests.